Difference between revisions of "MSK Biomarker Ctte"
Jump to navigation
Jump to search
(29 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
:Co-chairs: Thomas M. Link, MD, PhD; Xiaojuan Li, PhD | :Co-chairs: Thomas M. Link, MD, PhD; Xiaojuan Li, PhD | ||
− | : | + | :RSNA Staff Support: Susan Stanfa |
− | + | * [http://tinyurl.com/QIBA-MSK-Roster Roster] | |
The MSK Biomarker Committee seeks to develop a quantitative Profile for MSK. | The MSK Biomarker Committee seeks to develop a quantitative Profile for MSK. | ||
− | ==Meetings | + | |
− | *[[MSK Biomarker Committee Call Summaries]] | + | ==Meetings== |
+ | |||
+ | '''Approved call summaries:''' | ||
+ | *[[Media:2019_09-24_QIBA_MSK_Biomarker_Cmte_Call_Summary-FINAL.pdf|September 24, 2019]] | ||
+ | *[[Media:2019_06-25_QIBA_MSK_Biomarker_Cmte_Call_Summary-FINAL.pdf|June 25, 2019]] | ||
+ | *[[Media:2019_05-28_QIBA_MSK_Biomarker_Cmte_Call_Summary-FINAL.pdf|May 28, 2019]] | ||
+ | |||
+ | '''''[[MSK Biomarker Committee Call Summaries Archive]]''''' | ||
==Working Documents== | ==Working Documents== |
Revision as of 16:48, 22 October 2019
- Co-chairs: Thomas M. Link, MD, PhD; Xiaojuan Li, PhD
- RSNA Staff Support: Susan Stanfa
The MSK Biomarker Committee seeks to develop a quantitative Profile for MSK.
Meetings
Approved call summaries:
MSK Biomarker Committee Call Summaries Archive